FDA DrugClass IINotable

FDA Recall: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per c

Date: 2026-07-29
Brand: Major Pharmaceuticals
Category: Drug
FDA Class: Class II

Description

Subpotent Drug

Hazard

Subpotent Drug

Remedy

N/A

View original recall →
Share:

Related Recalls

2026-07-29 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose blisters per c
Major Pharmaceuticals
2026-07-29 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per c
Major Pharmaceuticals
2026-07-29 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per c
Major Pharmaceuticals
2026-07-29 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per car
Major Pharmaceuticals